Center for iPS Cell Research and Application (CiRA)

Combining cell transplantation and gene therapy to enhance axonal outgrowth in the central nervous system

Combining cell transplantation and gene therapy to enhance axonal outgrowth in the central nervous system

Global Engagement

The 1st Joint Symposium of Kyoto University's Three North American On-site Labs: Transformative Innovations in Medical and Life Sciences

A safer method of generating pancreatic islet-like cells from human iPS cells by inhibiting cyclin-dependent kinase CDK8/19

A safer method of generating pancreatic islet-like cells from human iPS cells by inhibiting cyclin-dependent kinase CDK8/19

Using organ-on-a-chip technology to elucidate the liver pathophysiology of COVID-19 patients

Using organ-on-a-chip technology to elucidate the liver pathophysiology of COVID-19 patients

Selective removal of undifferentiated iPS cells from mesenchymal stem cells

Questionable practices identified by an examination of therapeutic plan reviews performed by certified committees under the Act on the Safety of Regenerative Medicine

Questionable practices identified by an examination of therapeutic plan reviews performed by certified committees under the Act on the Safety of Regenerative Medicine

Pathogenesis of skeletal muscle lesions in spinal muscular atrophy

Cyclic RNA Switches that Regulate Gene Expression in a Cell Type-Specific Manner

Development of a versatile method to synthesize functional mRNAs with diverse 5' cap structures

Development of a versatile method to synthesize functional mRNAs with diverse 5' cap structures

T-Cell Responses in the Elderly Rise Slowly and Contract Quickly ~Learning About Individual and Age Differences in Immune Response From COVID-19 Vaccinations~

Modeling amyotrophic lateral sclerosis (ALS) in pigs -Developing a new experimental platform to test ALS gene and cell therapies-

Modeling amyotrophic lateral sclerosis (ALS) in pigs -Developing a new experimental platform to test ALS gene and cell therapies-

Reproducing skeletal muscle pathology of myotonic dystrophy using patient-derived iPS cells and establishing a new system to quantitatively evaluate drug efficacy

Reproducing skeletal muscle pathology of myotonic dystrophy using patient-derived iPS cells and establishing a new system to quantitatively evaluate drug efficacy

Genetic modifications boosting CAR signaling improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

Phase I clinical trial of bosutinib for amyotrophic lateral sclerosis (ALS); iDReAM study

A new sensitive method to detect for minute amounts of contaminating undifferentiated iPS cells

A new sensitive method to detect for minute amounts of contaminating undifferentiated iPS cells

2022 Clarivate Highly Cited Researchers include six from KyotoU